These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6186823)

  • 1. Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.
    Robertson BH; Moore DM; Grubman MJ; Kleid DG
    J Virol; 1983 Apr; 46(1):311-6. PubMed ID: 6186823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot-and-mouth disease and its antigens.
    Bachrach HL
    Adv Exp Med Biol; 1985; 185():27-46. PubMed ID: 2416203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus.
    Haresnape JM; King AM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2357-65. PubMed ID: 6196439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.
    Robertson BH; Morgan DO; Moore DM
    Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP.
    Bachrach HL; Morgan DO; McKercher PD; Moore DM; Robertson BH
    Vet Microbiol; 1982 May; 7(2):85-96. PubMed ID: 6287701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of the antigenic variation of foot-and-mouth disease virus.
    Beck E; Feil G; Strohmaier K
    EMBO J; 1983; 2(4):555-9. PubMed ID: 6194987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of a neutralization epitope of foot-and-mouth disease virus using neutralizing monoclonal antibodies.
    Duchesne M; Cartwright T; Crespo A; Boucher F; Fallourd A
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1559-66. PubMed ID: 6206202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages.
    Bachrach HL; Morgan DO; Moore DM
    Intervirology; 1979; 12(2):65-72. PubMed ID: 231585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface structure and RNA-protein interactions of foot-and-mouth disease virus.
    Morrell DJ; Mellor EJ; Rowlands DJ; Brown F
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1649-58. PubMed ID: 3035064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal amino acid sequences in the major capsid proteins of foot-and-mouth disease virus types A, O, and C.
    Matheka HD; Bachrach HL
    J Virol; 1975 Nov; 16(5):1248-53. PubMed ID: 171452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic comparison of the polypeptides of foot-and-mouth disease virus serotypes and other picornaviruses.
    Grubman MJ; Zellner M; Wagner J
    Virology; 1987 May; 158(1):133-40. PubMed ID: 2437694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of the outer structural protein VP1 of three different serotypes of foot-and-mouth disease virus.
    Meloen RH; Barteling SJ
    Virology; 1986 Feb; 149(1):55-63. PubMed ID: 2418582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus.
    Cheung A; DeLamarter J; Weiss S; Küpper H
    J Virol; 1983 Nov; 48(2):451-9. PubMed ID: 6194313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22].
    Onishchenko AM; Petrov NA; Blinov VM; Vasilenko SK; Sandakhchiev LS
    Bioorg Khim; 1986 Mar; 12(3):416-9. PubMed ID: 2421736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
    Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
    J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
    Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).
    Sobrino F; Martinez MA; Carrillo C; Beck E
    Virus Res; 1989 Dec; 14(4):273-80. PubMed ID: 2560293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.